MeetingsNews

Countdown to EyeCon Meeting

Countdown to the Ophthalmology Times Inaugural EyeCon Meeting 2021

November 29, 2021

Lynda Charters

Save the dates for this virtual interactive conference featuring top US ophthalmologists

The Ophthalmology Times® Inaugural EyeCon 2021 virtual interactive conference featuring renowned investigators is slated for December 10-11, 2021, and registration is now open. The sessions will run from 8:30 am to 3:55 pm on both days.

Don’t miss this opportunity to access information on the latest insights and advancements in a variety of ophthalmic topics and get CME credits at the same time!

The conference, co-chaired by Peter J. McDonnell, MD, director of the Wilmer Eye Institute, and Texas-based glaucoma specialist Oluwatosin U. Smith, MD, associate professor, Department of Ophthalmology, University of Texas Southwestern, Dallas, will bring together the nation’s top ophthalmology experts to share new data and clinical insight into the most current processes and therapeutics.

Participants will have the opportunity to optimize the use of imaging and other diagnostic tools for earlier identification of ocular diseases, improve team-based interactions with other eye-care specialists and health care providers when treating patients with systemic diseases contributing to vision loss, gain confidence in the use of new and emerging therapies and procedures in the ophthalmology setting, and interact with expert faculty to implement key learnings into practice.

The planned topics to look forward to, according to Drs. McDonnell and Smith, include advances in older topics of interest to ophthalmologist and updates on treatments on the horizon, many of these life-changing. These discussions include investigational and newly approved therapies for geographic atrophy, neovascular age-related macular degeneration, thyroid eye disease, and neuromyelitis optica spectrum disease; sustained drug delivery and minimally invasive glaucoma surgery; advances in cataract and refractive surgery; gene therapy for retinal disease and other ocular conditions; telemedicine during COVID-19; and the latest strategies for managing common concerns, including uveitis, presbyopia, and dry eye disease.

Don’t miss out! Use this link for more information on the conference agenda, faculty, and registration: Event Info

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.